AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
A concise guide to planning Social Security timing from a 30s perspective, covering factors that affect when to start and how it influences lifetime benefits.
20,028 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
A major strategic move lands in Voyager Technologies’ lap as it closes the Astrobotic acquisition while securing a he...
Investors are turning to ASML to gauge the health of the global chip cycle. This article breaks down the factors like...
A closer look at Janus Henderson's CLO ETFs shows a safety-first anchor in JAAA and a bolder, higher-yield challenger...
A fresh Council of Economic Advisers report challenges the net cost figures tied to CFPB rules, arguing higher rates ...
SoundHound AI is pursuing an enterprise voice AI niche built on data ownership and brand protection. This article bre...
When a top executive sells shares as a company commits billions to its hubs, it can spark questions. This article bre...
Gold has rallied about 73% over the past year as inflation jitters fade and risk-off trades surge. This report shows ...
Cactus (WHD) finishes 2025 with solid top-line growth and steadier margins. This report breaks down cactus (whd) 2025...
Massachusetts shed about 182,000 residents in five years, driven by tax and cost-of-living pressures, according to a ...
As Archer Aviation moves toward broader commercial programs, investors need a clear view of 2025 earnings drivers. Th...
When the holiday season closed, Ross Stores delivered a clear message: steady demand for its off-price model and a ca...